Alkermes ALKS
NASDAQ ALKS
$46.17 +0.27 (+0.59%)
At close: Nov 9, 2026 · 4:00 PM EST

Alkermes (ALKS) Interest Paid (2011 - 2013)

Updated

Alkermes (ALKS) reported Interest Paid of $23.01 million for FY2024, up 1.2% from $22.75 million in FY2023.

Analysis

Alkermes (ALKS) Interest Paid (2011 - 2013) Analysis & Trends

Dating back to FY2010, Alkermes' Interest Paid record includes 15 years.

  • Interest Paid has increased for three consecutive years, with a five-year compound annual growth rate of 11.7% (FY2019 to FY2024).
  • The FY2024 figure ranks as the highest annual Interest Paid in data going back to FY2010.
  • According to Business Quant data, Interest Paid came in at $22.75 million in FY2023 (+67.7%), $13.56 million in FY2022 (+96.5%), $6.9 million in FY2021 (-16.7%) and $8.29 million in FY2020 (-37.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 283.00 Mn
10 Alkermes 7.77 Bn 5.26 Bn 385.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -12.84 Mn
Dec 31, 2012 3.16 Mn
Sep 30, 2012 10.63 Mn
Jun 30, 2012 8.64 Mn
Mar 31, 2012 8.18 Mn
Dec 31, 2011 7.61 Mn
API Access

Alkermes Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=ALKS&period=max&api_key=YOUR_API_KEY